"This week, Elle magazine published an interview with Serena Williams, in which she revealed and explained her use of GLP-1 drugs for her recent weight loss. She is a famous tennis champion, but also a brand ambassador for one of the emerging telehealth companies that is making Ozempic, Zepbound, and similar medications more readily available for "off-label" use. These online businesses are particularly serving those, like Williams, who may not clinically be defined as "obese" but still want to shed unwanted pounds."
"Williams, however, also shared that her purpose in speaking out about her GLP-1 success story is to counter stigma around using these drugs, especially the belief that their use is somehow "cheating" at weight loss. "It's ok to be on them," she said.I've heard this same claim of "cheating" often in our research on the experiences of bariatric surgery patients."
Serena Williams used GLP-1 drugs to lose "extra mom weight" and to feel confident and healthy. She serves as a brand ambassador for an emerging telehealth company that facilitates access to Ozempic, Zepbound, and similar medications for off-label weight loss. These services often target people who are not clinically obese but seek unwanted-pound reduction. Williams stated that speaking publicly aimed to counter the belief that drug-assisted weight loss is "cheating," saying "It's ok to be on them." Moral judgments that valorize exercise and extreme dieting and high out-of-pocket drug costs risk increasing stigma toward people who remain fat.
Read at Psychology Today
Unable to calculate read time
Collection
[
|
...
]